Evidence map›Paper›PMID 41379632›Full record

ArticleEpilepsia open2025

Natural language processing-based emotion and usage analysis of an AI-powered chatbot for epilepsy support.

Keiichi Watanuki, Ryoya Oba, Naoki Nozawa, Tomoki Ishihara, Koko Oga, Takayuki Iwayama, Takafumi Shiganami, Sayaka Kobayashi, Hironori Kuga, Haruo Yoshimasu and 1 more

Abstract read
In one paragraph

Article in Epilepsia open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Keiichi WatanukiGraduate School of Science and Engineering, Saitama University, Saitama, Japan.
Ryoya ObaGraduate School of Science and Engineering, Saitama University, Saitama, Japan.
Naoki NozawaGraduate School of Science and Engineering, Saitama University, Saitama, Japan.
Tomoki IshiharaDepartment of Medicine, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Koko OgaDepartment of Psychiatry, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Takayuki IwayamaDepartment of Psychiatry, Saitama Medical Center, Saitama Medical University, Saitama, Japan.ORCID https://orcid.org/0000-0003-2191-4146
Takafumi ShiganamiDepartment of Psychiatry, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Sayaka KobayashiDepartment of Psychiatry, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Hironori KugaNational Center of Neurology and Psychiatry, Cognitive Behavioral Therapy Center, Tokyo, Japan.
Haruo YoshimasuDepartment of Psychiatry, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Izumi KuramochiDepartment of Psychiatry, Saitama Medical Center, Saitama Medical University, Saitama, Japan.ORCID https://orcid.org/0000-0002-6416-5213

Funding

Collaborative Research Support Grant Saitama University and Saitama Medical University 23J13Japan Epilepsy Research Foundation 23006KAKENHI 21K13709
6 · The paper itself

Abstract

objectiveArtificial intelligence (AI)-powered chatbots are increasingly used for patient education and mental health support, yet their effectiveness in epilepsy care remains underexplored. This study examines text-based interactions between users and EpiloBot, an epilepsy-focused chatbot, to understand conversational patterns and emotional trends using natural language processing (NLP) techniques.

methodsText interactions from the chatbot's pretest phase (a total of 23 participants; 10 people with epilepsy, PWE, 10 caregivers, and 3 healthcare professionals) were analyzed using JMedRoBERTa (Japanese Medical RoBERTa, a model fine-tuned on Japanese medical literature) to classify user messages into content clusters and DeBERTa (Decoding-enhanced BERT with Disentangled Attention, a model developed by Microsoft Research) to track emotional shifts. For sentiment analysis, only five PWE who interacted frequently with EpiloBot (more than 80 times) were included. The study employed UMAP (Uniform Manifold Approximation and Projection) clustering and k-means algorithms to differentiate between objective medical inquiries and subjective, nonurgent queries. Sentiment analysis was conducted to explore the chatbot's influence on emotional engagement.

resultsTwo primary content clusters were identified: "Medical Inquiry Cluster"-Objective, treatment-related questions about epilepsy medications and management strategies. "Exploratory Use Cluster"-Subjective or emotional inquiries, often focused on coping strategies and personal reflection. Sentiment analysis using DeBERTa revealed that messages related to proactive learning (e.g., gaining social skills) were associated with increased positive emotions, while introspective, self-evaluative messages showed reduced positivity. These findings provide insights into how chatbots influence user emotions and engagement patterns. SIGNIFICANCE: NLP-based chatbot analyses offer valuable insights into patient engagement and emotional support needs. The study highlights the importance of designing chatbots that balance medical guidance with psychological support, particularly for chronic disease management. Future improvements in chatbot algorithms should focus on context-aware interactions and empathic response generation to optimize patient outcomes. PLAIN LANGUAGE SUMMARY: This study analyzed how people interacted with EpiloBot, an artificial intelligence (AI)-powered chatbot for epilepsy education and support. Using advanced language processing (NLP) techniques, we examined user messages to understand chatbot usage patterns and emotional responses. Results showed that users engaged in two main ways: medical inquiries about epilepsy treatment and exploratory, nonurgent conversations. Emotion analysis revealed that proactive learning interactions increased positive emotions, while self-reflective questions led to more neutral or negative sentiments. These findings suggest that chatbots can provide emotional benefits, but future improvements should focus on empathetic AI responses and personalized support.

Indexed as

AI chatbotsDeBERTaemotion trackingepilepsy supportJMedRoBERTamachine learningnatural language processing (NLP)sentiment analysis

Identifiers

PMID41379632
PMCPMC13394615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.